Technology
Health
Medical

IntriCon

$22.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.31 (1.41%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell IntriCon and other stocks, options, ETFs, and crypto commission-free!

About

Intricon Corp. engages in the design, development, engineering, manufacture, and distribution of miniature and micro-miniature body-worn devices. It operates through the Body-Worn Device and Hearing Health Direct-To-Consumer segments. Read More The Body-Worn Device segment comprises medical, hearing health, and professional audio markets. The Hearing Health Direct-To-Consumer segment provides advanced hearing products such as ultra-miniature volume controls and trimmers, custom amplifiers, and custom, completed hearing instruments. The company was founded in 1930 and is headquartered in Arden Hills, MN.

Employees
810
Headquarters
Arden Hills, Minnesota
Founded
1930
Market Cap
191.13M
Price-Earnings Ratio
34.24
Dividend Yield
0.00
Average Volume
209.09K
High Today
$22.71
Low Today
$22.04
Open Price
$22.18
Volume
72.94K
52 Week High
$76.80
52 Week Low
$18.60

Collections

Technology
Health
Medical
Engineering
US
North America

News

Simply Wall StMar 12

IntriCon Corporation (NASDAQ:IIN): What Does Its Beta Value Mean For Your Portfolio?

If you own shares in IntriCon Corporation (NASDAQ:IIN) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall.

26
MarketBeatMar 7

Stock Price, News, & Analysis for IntriCon

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally.

5
Seeking AlphaFeb 20

IntriCon down 15% post Q4 results; provides FY19 guidance

IntriCon (IIN -15.2% ) reported Q4 revenue growth of 41.1% Y/Y to $30.4M, the increase was due to Y/Y revenue gains from largest medical customer and growth in value-based indirect-to-end-consumer hearing healthcare business.

81

Earnings

$0.04
$0.11
$0.18
$0.25
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.